Michalis Aivaliotis
Overview
Explore the profile of Michalis Aivaliotis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
707
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodrigues-Junior D, Tsirigoti C, Psatha K, Kletsas D, Aivaliotis M, Heldin C, et al.
J Exp Clin Cancer Res
. 2025 Feb;
44(1):42.
PMID: 39910665
Background: Cancer cells are avid extracellular vesicle (EV) producers. EVs transport transforming growth factor-β (TGF-β), which is commonly activated under late stages of cancer progression. Nevertheless, whether TGF-β signaling coordinates...
2.
Mavridou D, Psatha K, Aivaliotis M
J Pers Med
. 2024 Aug;
14(8).
PMID: 39202022
Chronic Lymphocytic Leukemia (CLL) is the most common B-cell malignancy in the Western world, characterized by frequent relapses despite temporary remissions. Our study integrated publicly available proteomic, transcriptomic, and patient...
3.
Varna D, Geromichalos G, Dalezis P, Hatzidimitriou A, Psomas G, Zachariadis G, et al.
Eur J Med Chem
. 2024 Aug;
277:116746.
PMID: 39146831
Metal complexes showing dual activity against cancer and bacterial infections are currently the focus of significant interest for their potential in treating life-threatening diseases. Aiming to investigate the impact of...
4.
Orfanoudaki G, Psatha K, Aivaliotis M
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 39000404
Mantle cell lymphoma (MCL) is a rare, incurable, and aggressive B-cell non-Hodgkin lymphoma (NHL). Early MCL diagnosis and treatment is critical and puzzling due to inter/intra-tumoral heterogeneity and limited understanding...
5.
Papakonstantinou E, Dragoumani K, Mataragka A, Bacopoulou F, Yapijakis C, Balatsos N, et al.
EMBnet J
. 2024 Jun;
29.
PMID: 38845752
Breast milk, often referred to as "liquid gold," is a complex biofluid that provides essential nutrients, immune factors, and developmental cues for newborns. Recent advancements in the field of exosome...
6.
Kourti M, Aivaliotis M, Hatzipantelis E
Diagnostics (Basel)
. 2023 Sep;
13(17).
PMID: 37685286
Acute lymphoblastic leukemia (ALL) is the most common cancer in children and one of the success stories in cancer therapeutics. Risk-directed therapy based on clinical, biologic and genetic features has...
7.
Psatha K, Kollipara L, Drakos E, Deligianni E, Brintakis K, Patsouris E, et al.
Cancers (Basel)
. 2023 Aug;
15(15).
PMID: 37568720
In most lymphomas, p53 signaling pathway is inactivated by various mechanisms independent to p53 gene mutations or deletions. In many cases, p53 function is largely regulated by alterations in the...
8.
Kountourantzis A, Minoudi S, Karaiskou N, Papakostas S, Moulistanos A, Baka R, et al.
Res Vet Sci
. 2023 Jul;
162:104959.
PMID: 37480717
Canine degenerative myelopathy (CDM) is a late-onset fatal disorder associated with a point mutation of the superoxide dismutase 1 (SOD1) gene (c.118G > A). The purpose of this study was...
9.
Devranis P, Vassilopoulou E, Tsironis V, Sotiriadis P, Chourdakis M, Aivaliotis M, et al.
Life (Basel)
. 2023 Jan;
13(1).
PMID: 36676122
(1) Background: Compelling evidence shows that dietary patterns can slow the rate of cognitive decline, suggesting diet is a promising preventive measure against dementia. (2) Objective: This systematic review summarizes...
10.
Papagiannopoulos C, Kyritsis K, Psatha K, Mavridou D, Chatzopoulou F, Orfanoudaki G, et al.
Front Mol Biosci
. 2022 Feb;
9:805541.
PMID: 35187080
Heterogeneity of the main ribosomal composition represents an emerging, yet debatable, mechanism of gene expression regulation with a purported role in ribosomopathies, a group of disorders caused by mutations in...